Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | isocitrate dehydrogenase | 0.0016 | 0.0002 | 0.0005 |
Loa Loa (eye worm) | TAR-binding protein | 0.0062 | 0.3096 | 1 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0016 | 0.0002 | 0.5 |
Leishmania major | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0016 | 0.0002 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.3096 | 0.3096 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0049 | 0.2218 | 0.7163 |
Plasmodium falciparum | isocitrate dehydrogenase [NADP], mitochondrial | 0.0016 | 0.0002 | 0.5 |
Plasmodium vivax | isocitrate dehydrogenase [NADP], mitochondrial, putative | 0.0016 | 0.0002 | 0.5 |
Trypanosoma brucei | isocitrate dehydrogenase, putative | 0.0016 | 0.0002 | 0.5 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0016 | 0.0002 | 0.0002 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0049 | 0.2218 | 0.7163 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0016 | 0.0002 | 0.0002 |
Schistosoma mansoni | hypothetical protein | 0.0167 | 1 | 1 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0016 | 0.0002 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0049 | 0.2218 | 0.7163 |
Echinococcus multilocularis | geminin | 0.0167 | 1 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0062 | 0.3096 | 1 |
Brugia malayi | Isocitrate dehydrogenase | 0.0016 | 0.0002 | 0.0005 |
Trypanosoma cruzi | isocitrate dehydrogenase, putative | 0.0016 | 0.0002 | 0.5 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0034 | 0.1191 | 0.3848 |
Schistosoma mansoni | NADP-specific isocitrate dehydrogenase | 0.0016 | 0.0002 | 0.0002 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.3096 | 0.3096 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.3096 | 0.3096 |
Brugia malayi | isocitrate dehydrogenase | 0.0016 | 0.0002 | 0.0005 |
Schistosoma mansoni | hypothetical protein | 0.0167 | 1 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.0062 | 0.3096 | 0.3096 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0062 | 0.3096 | 1 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0062 | 0.3096 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.3096 | 0.3096 |
Trypanosoma cruzi | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0016 | 0.0002 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0034 | 0.1191 | 0.1191 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0016 | 0.0002 | 0.0002 |
Brugia malayi | TAR-binding protein | 0.0062 | 0.3096 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.1191 | 0.3848 |
Brugia malayi | RNA binding protein | 0.0062 | 0.3096 | 1 |
Echinococcus multilocularis | isocitrate dehydrogenase | 0.0016 | 0.0002 | 0.0002 |
Echinococcus multilocularis | isocitrate dehydrogenase 2 (NADP+) | 0.0016 | 0.0002 | 0.0002 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0016 | 0.0002 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.2218 | 0.7163 |
Trypanosoma brucei | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0016 | 0.0002 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.3096 | 0.3096 |
Echinococcus granulosus | NADP dependent isocitrate dehydrogenase | 0.0016 | 0.0002 | 0.0002 |
Echinococcus granulosus | tar DNA binding protein | 0.0062 | 0.3096 | 0.3096 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | <= 54 % | Inhibition of Amyloid beta (1 to 42) (unknown origin) oligomer assembly at Abeta:compound ratio of 0.0002 after 30 mins by single-site ELISA assay | ChEMBL. | 25537270 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.